Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 1
2002 5
2003 1
2004 3
2010 11
2011 6
2012 8
2013 2
2014 6
2015 4
2016 7
2017 6
2018 8
2019 5
2020 4
2021 6
2022 1
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

77 results

Results by year

Filters applied: . Clear all
Page 1
Bruton tyrosine kinase inhibitors for multiple sclerosis.
Krämer J, Bar-Or A, Turner TJ, Wiendl H. Krämer J, et al. Among authors: turner tj. Nat Rev Neurol. 2023 May;19(5):289-304. doi: 10.1038/s41582-023-00800-7. Epub 2023 Apr 13. Nat Rev Neurol. 2023. PMID: 37055617 Free PMC article. Review.
Safety and efficacy of tolebrutinib, an oral brain-penetrant BTK inhibitor, in relapsing multiple sclerosis: a phase 2b, randomised, double-blind, placebo-controlled trial.
Reich DS, Arnold DL, Vermersch P, Bar-Or A, Fox RJ, Matta A, Turner T, Wallström E, Zhang X, Mareš M, Khabirov FA, Traboulsee A; Tolebrutinib Phase 2b Study Group. Reich DS, et al. Among authors: turner t. Lancet Neurol. 2021 Sep;20(9):729-738. doi: 10.1016/S1474-4422(21)00237-4. Lancet Neurol. 2021. PMID: 34418400 Free PMC article. Clinical Trial.
Idiopathic Pulmonary Comorbidities and Mechanisms.
Pacurari M, Mitra A, Turner T. Pacurari M, et al. Among authors: turner t. Int J Inflam. 2021 Oct 13;2021:3963659. doi: 10.1155/2021/3963659. eCollection 2021. Int J Inflam. 2021. PMID: 34691383 Free PMC article. Review.
Growth factor-induced cell motility in tumor invasion.
Wells A, Kassis J, Solava J, Turner T, Lauffenburger DA. Wells A, et al. Among authors: turner t. Acta Oncol. 2002;41(2):124-30. doi: 10.1080/028418602753669481. Acta Oncol. 2002. PMID: 12102155 Review.
Racial Disparities and Preventive Measures to Renal Cell Carcinoma.
Sims JN, Yedjou CG, Abugri D, Payton M, Turner T, Miele L, Tchounwou PB. Sims JN, et al. Among authors: turner t. Int J Environ Res Public Health. 2018 May 28;15(6):1089. doi: 10.3390/ijerph15061089. Int J Environ Res Public Health. 2018. PMID: 29843394 Free PMC article.
An IP-10 (CXCL10)-derived peptide inhibits angiogenesis.
Yates-Binder CC, Rodgers M, Jaynes J, Wells A, Bodnar RJ, Turner T. Yates-Binder CC, et al. Among authors: turner t. PLoS One. 2012;7(7):e40812. doi: 10.1371/journal.pone.0040812. Epub 2012 Jul 16. PLoS One. 2012. PMID: 22815829 Free PMC article.
77 results